# Bioinformation Therapy for Pancreatic Cancer

> **NCT03239184** · PHASE2,PHASE3 · COMPLETED · sponsor: **Fuda Cancer Hospital, Guangzhou** · enrollment: 120 (actual)

## Conditions studied

- Unresectable Pancreatic Cancer

## Interventions

- **DEVICE:** Cancer ablation
- **DRUG:** Life information rehabilitation therapy

## Key facts

- **NCT ID:** NCT03239184
- **Lead sponsor:** Fuda Cancer Hospital, Guangzhou
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-01
- **Primary completion:** 2018-09-01
- **Final completion:** 2018-09-01
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2019-01-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03239184

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03239184, "Bioinformation Therapy for Pancreatic Cancer". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT03239184. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*